Distinctive and critical roles for cellular immunity and immune-inflammatory response in the immunopathology of Sendai virus infection in mice

Microbes and Infection

Volumn 13, Issue 8-9, 2011, Pages 783-797

  Simon, Ayo Yila ^a   Sasaki, Nobuya ^a   Ichii, Osamu ^a   Kajino, Kiichi ^b   Kon, Yasuhiro ^a   Agui, Takashi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cellular immunity; Gene expression analysis; Immune inflammatory response; Immunopathology; Inbred mouse; Sendai virus (HVJ)

Indexed keywords

CARBON TETRACHLORIDE; CCL1 CHEMOKINE; EOTAXIN; EOTAXIN 2; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 16; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 5; RANTES; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ANIMAL CELL; ARTICLE; C57BL 6 MOUSE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DBA 2 MOUSE; FEMALE; FUNCTIONAL GENOMICS; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LUNG LAVAGE; MONONUCLEAR CELL; MOUSE; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SENDAI VIRUS INFECTION; VIRUS STRAIN;

ANALYSIS OF VARIANCE; ANIMALS; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HISTOCYTOCHEMISTRY; HOST-PATHOGEN INTERACTIONS; IMMUNITY, CELLULAR; INFLAMMATION; LUNG; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; RESPIROVIRUS INFECTIONS; SENDAI VIRUS;

MUS; PARAMYXOVIRIDAE; SENDAI VIRUS;

EID: 79959914684     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.04.003     Document Type: Article

References (50)

1. Williams B.G., Gouws E., Boschi-Pinto C., Bryce J., Dye C. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect. Dis. 2002, 2:25-32.
2. Chanock R.M., Murphy B.R., Collins P.L. Fields Virology 2001, 1341-1379. Lippincott, Williams, & Wilkins, Philadelphia. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Strauss (Eds.).
3. de Jong M.D., Simmons C.P., Thanh T.T., Hien V.M., Smith G.J., Chau T.N., Hoang D.M., Chau N.V., Khanh T.H., Dong V.C., Qui P.T., Cam B.V., Ha do Q., Guan Y., Peiris J.S., Chinh N.T., Hien T.T., Farrar J. Fatal outcome of human influenza a (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 2006, 12:1203-1207.
4. Gern J.E., Brooks G.D., Meyer P., Chang A., Shen K., Evans M.D., Tisler C., Dasilva D., Roberg K.A., Mikus L.D., Rosenthal L.A., Kirk C.J., Shult P.A., Bhattacharya A., Li Z., Gangnon R., Lemanske R.F. Bidirectional interactions between viral respiratory illnesses and cytokine responses in the first year of life. J. Allergy Clin. Immunol. 2006, 117:72-78.
5. Laham F.R., Israele V., Casellas J.M., Garcia A.M., Lac Prugent C.M., Hoffman S.J., Hauer D., Thumar B., Name M.I., Pascual A., Taratutto N., Ishida M.T., Balduzzi M., Maccarone M., Jackli S., Passarino R., Gaivironsky R.A., Karron R.A., Polack N.R., Polack F.P. Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy. J. Infect. Dis. 2004, 189:2047-2056.
6. Melendi G.A., Laham F.R., Monsalvo A.C., Casellas J.M., Israele V., Polack N.R., Kleeberger S.R., Polack F.P. Cytokine profiles in the respiratory tract during primary infection with human metapneumovirus, respiratory syncytial virus, or influenza virus in infants. Pediatrics 2007, 120:e410-415.
7. Gorman W.L., Gill D.S., Scroggs R.A., Portner A. The hemagglutinin neuraminidase glycoproteins of human parainfluenza virus type 1 and sendai virus have high structure-function similarity with limited antigenic cross-reactivity. Virology 1990, 175:211-221.
8. Lyn D., Gill D.S., Scroggs R.A., Portner A. The nucleoproteins of human parainfluenza virus type 1 and sendai virus share amino acid sequences and antigenic and structural determinants. J. Gen. Virol. 1991, 72:983-987.
9. Skiadopoulos M.H., Surman S.R., Riggs J.M., Elkins W.R., St Claire M., Nishio M., Garcin D., Kolakofsky D., Collins P.L., Murphy B.R. Sendai virus, a murine parainfluenza virus type 1, replicates to a level similar to human piv1 in the upper and lower respiratory tract of african green monkeys and chimpanzees. Virology 2002, 297:153-160.
10. Hurwitz J.L. Development of recombinant sendai virus vaccines for prevention of human parainfluenza and respiratory syncytial virus infections. Pediatr. Infect. Dis. J. 2008, 27:S126-S128.
11. Boeckh M. The challenge of respiratory virus infections in hematopoietic cell transplant recipients. Br. J. Haematol. 2008, 143:455-467.
12. Faisca P., Desmecht D. Sendai virus, the mouse parainfluenza type 1: a longstanding pathogen that remains up-to-date. Res. Vet. Sci. 2007, 82:115-125.
13. Collins P.L., Graham B.S. Viral and host factors in human respiratory syncytial virus pathogenesis. J. Virol. 2008, 82:2040-2055.
14. Openshaw P.J., Tregoning J.S. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin. Microbiol. Rev. 2005, 18:541-555.
15. Haeberle H.A., Kuziel W.A., Dieterich H.J., Casola A., Gatalica Z., Garofalo R.P. Inducible expression of inflammatory chemokines in respiratory syncytial virus- infected mice: role of MIP-1alpha in lung pathology. J. Virol. 2001, 75:878-890.
16. McNamara P.S., Flanagan B.F., Hart C.A., Smyth R.L. Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J. Infect. Dis. 2005, 191:1225-1232.
17. Culley F.J., Pennycook A.M., Tregoning J.S., Dodd J.S., Walzl G., Wells T.N., Hussell T., Openshaw P.J. Role of CCL5 (RANTES) in viral lung disease. J. Virol. 2006, 80:8151-8157.
18. Amanatidou V.G., Sourvinos S., Apostolakis A., Tsilimigaki A., Spandidos D.A. T280M variation of the CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus bronchiolitis. Pediatr. Infect. Dis. J. 2006, 25:410-414.
19. Tregoning J.S., Pribul P.K., Pennycook A.M.J., Hussell T., Wang B., Lukacs N., Schwarze J., Culley F.J., Openshaw P.J. The chemokine MIP1a/CCL3 determines pathology in primary RSV Infection by regulating the balance of T cell populations in the murine lung. PLoS ONE 2010, 5:e9381.
20. Simon A.Y., Moritoh K., Torigoe D., Asano A., Sasaki N., Agui T. Multigenic control of resistance to sendai virus infection in mice. Infect. Genet. Evol. 2009, 9:1253-1259.
21. Faisca P., Anh D.B., Desmecht D.J. Sendai virus-induced alterations in lung structure/function correlate with viral loads and reveal a wide resistance/susceptibility spectrum among mouse strains. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:L777-L787.
22. Hou S., Doherty P.C., Zijlstra M., Jaenisch R., Katz J.M. Delayed clearance of sendai virus in mice lacking class I MHC-restricted CD8+ T cells. J. Immunol. 1992, 149:1319-1325.
23. Zhong W., Roberts A.D., Woodland D.L. Antibody-independent antiviral function of memory CD4+ T cells in vivo requires regulatory signals from CD8+ effector T cells. J. Immunol. 2001, 167:1379-1386.
24. Kim E.Y., Battaile J.T., Patel A.C., You Y., Agapov E., Grayson M.H., Benoit L.A., Byers D.E., Alevy Y., Tucker J., Swanson S., Tidwell R., Tyner J.W., Morton J.D., Castro M., Polineni D., Patterson G.A., Schwendener R.A., Allard J.D., Peltz G., Holtzman M.J. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med. 2008, 14:633-640.
25. Matikainen S., Pirhonen J., Miettinen M., Lehtonen A., Govenius-Vintola C., Sareneva T., Julkunen I. Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages. Virology 2000, 276:138-147.
26. Elco C.P., Guenther J.M., Williams B.R., Sen G.C. Analysis of genes induced by sendai virus infection of mutant cell lines reveals essential roles of interferon regulatory factor 3, NF-kappaB, and interferon but not toll-like receptor 3. J. Virol. 2005, 79:3920-3929.
27. Cai X., Castleman W.L. Increased IFN-gamma protein in bronchoalveolar lavage fluid of anti-IP-10 antibody-treated F344 rats following sendai viral infection. J. Interferon Cytokine Res. 2002, 22:1175-1179.
28. Tregoning J.S., Yamaguchi Y., Harker J., Wang B., Openshaw P.J. The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice. J. Virol. 2008, 82:4115-4124.
29. Boon A.C., deBeauchamp J., Hollmann A., Luke J., Kotb M., Rowe S., Finkelstein D., Neale G., Lu L., Williams R.W., Webby R.J. Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza a virus in mice. J. Virol. 2009, 83:10417-10426.
30. Chan M.C., Cheung C.Y., Chui W.H., Tsao S.W., Nicholls J.M., Chan Y.O., Chan R.W., Long H.T., Poon L.L., Guan Y., Peiris J.S. Pro-inflammatory cytokine responses induced by influenza a (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir. Res. 2005, 5:135.
31. Mo X.Y., Sarawar S.R., Doherty P.C. Induction of cytokines in mice with parainfluenza pneumonia. J. Virol. 1995, 69:1288-1291.
32. Veckman V., Osterlund P., Fagerlund R., Melen K., Matikainen S., Julkunen I. TNF-alpha and IFN-alpha enhance influenza-a-virus-induced chemokine gene expression in human A549 lung epithelial cells. Virology 2006, 345:96-104.
33. Hu X., Ivashkiv L.B. Cross-regulation of signaling pathways by interferon-gamma: Implications for immune responses and autoimmune diseases. Immunity 2009, 31:539-550.
34. Cameron M.J., Ran L., Xu L., Danesh A., Bermejo-Martin J.F., Cameron C.M., Muller M.P., Gold W.L., Richardson S.E., Poutanen S.M., Willey B.M., DeVries M.E., Fang Y., Seneviratne C., Bosinger S.E., Persad D., Wilkinson P., Greller L.D., Somogyi R., Humar A., Keshavjee S., Louie M., Loeb M.B., Brunton J., McGeer A.J., Kelvin D.J. Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J. Virol. 2007, 81:8692-8706. Canadian SARS Research Network.
35. Cheung C.Y., Poon L.L., Lau A.S., Luk W., Lau Y.L., Shortridge K.F., Gordon S., Guan Y., Peiris J.S. Induction of pro-inflammatory cytokines in human macrophages by influenza a (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 2002, 360:1831-1837.
36. Szretter K.J., Gangappa S., Lu X., Smith C., Shieh W.J., Zaki S.R., Sambhara S., Tumpey T.M., Katz J.M. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J. Virol. 2007, 81:2736-2744.
37. Akk A.M., Simmons P.M., Chan H.W., Agapov E., Holtzman M.J., Grayson M.H., Pham C.T. Dipeptidyl peptidase i-dependent neutrophil recruitment modulates the inflammatory response to sendai virus infection. J. Immunol. 2008, 180:3535-3542.
38. Wohlleben G., Erb K.J. The absence of IFN-gamma leads to increased TH2 responses after influenza a virus infection characterized by an increase in CD4+ but not CD8+ T cells producing IL-4 or IL-5 in the lung. Immunol. Lett. 2004, 95:161-166.
39. Stone A.E., Giguere S., Castleman W.L. IL-12 reduces the severity of sendai virus-induced bronchiolar inflammation and remodeling. Cytokine 2003, 24:103-113.
40. Monteiro J.M., Harvey C., Trinchieri G. Role of interleukin-12 in primary influenza virus infection. J. Virol. 1998, 72:4825-4831.
41. Romani L., Puccetti P., Bistoni F. Interleukin-12 in infectious diseases. Clin. Microbiol. Rev. 1997, 10:611-636.
42. Mo X.Y., Sangster M.Y., Tripp R.A., Doherty P.C. Modification of the sendai virus-specific antibody and CD8+ T-cell responses in mice homozygous for disruption of the interleukin-4 gene. J. Virol. 1997, 71:2518-2521.
43. Sun J., Madan R., Karp C.L., Braciale T.J. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 2009, 15:277-284.
44. Miller A.L., Bowlin T.L., Lukacs N.W. Respiratory syncytial virus-induced chemokine production: Linking viral replication to chemokine production in vitro and in vivo. J. Infect. Dis. 2004, 189:1419-1430.
45. Zhang Y., Luxon B.A., Casola A., Garofalo R.P., Jamaluddin M., Brasier A.R. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J. Virol. 2001, 75:9044-9058.
46. Kohlmeier J.E., Miller S.C., Smith J., Lu B., Gerard C., Cookenham T., Roberts A.D., Woodland D.L. The chemokine receptor Ccr5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity 2008, 29:101-113.
47. Tyner J.W., Uchida O., Kajiwara N., Kim E.Y., Patel A.C., O'Sullivan M.P., Walter M.J., Schwendener R.A., Cook D.N., Danoff T.M., Holtzman M.J. Ccl5-Ccr5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat. Med. 2005, 11:1180-1187.
48. Kim T.S., Braciale T.J. Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS One 2009, 4:e4204.
49. Chen J., Ng M.M., Chu J.J. Molecular profiling of T-helper immune genes during dengue virus infection. Virol. J. 2008, 5:165.
50. Alberts R., Srivastava B., Wu H., Viegas N., Geffers R., Klawonn F., Novoselova N., do Valle T.Z., Panthier J.J., Schughart K. Gene expression changes in the host response between resistant and susceptible inbred mouse strains after influenza A infection. Microbes. Infect. 2010, 12:309-318.